Dual drivers of polypharmacy in people with HIV : Quantifying the independent associations of aging and long‐term antiretroviral therapy
HIV Medicine · 2025
DOI: 10.1111/hiv.70106 ↗Kurz gefasst
Fachartikel in der Zeitschrift HIV Medicine, 2025. Verfasst von Shigeru Hasebe und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Social Pharmacy, Faculty of Pharmaceutical Sciences, Setsunan University, Hirakata, Osaka, Japan. Hauptthemen laut MEDLINE: Polypharmacy, HIV Infections, Aging, Anti-HIV Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Themen: Medikationssicherheit
Abstract (Originalsprache)
Objectives
This study aimed to disentangle the independent effects of aging and cumulative antiretroviral therapy (ART) duration on polypharmacy in people with HIV. While successful ART has led to an aging population with HIV, polypharmacy may stem from both aging and ART's cumulaftive toxicity. Quantitative evidence separating these effects is scarce, particularly in Japan.
Methods
In this retrospective study, we analysed a Japanese community pharmacy database (2014–2022) of 696 people on ART for ≥6 months. Using negative binomial regression, we assessed the independent effects of age and cumulative ART duration on the number of concomitant medications (a proxy for polypharmacy), adjusting for sex.
Results
Both advanced age and cumulative ART duration were significant independent risk factors for polypharmacy. A strong dose‐dependent relationship was observed with age (incidence rate ratio [IRR] for 60–69 years: 9.61; 95% confidence interval [CI], 4.92–18.78 vs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Social Pharmacy, Faculty of Pharmaceutical Sciences, Setsunan University, Hirakata, Osaka, Japan.
- Laboratory of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Setsunan University, Hirakata, Osaka, Japan.
- Department of Pharmacy, National Hospital Organization Osaka Minami Medical Center, Kawachinagano, Osaka, Japan.
- Hoenzaka Medical Company, Limited, Osaka, Osaka, Japan.
ORCID-Profile: Shigeru Hasebe, Shiori Iwane, Maho Kikuta
Zitieren
APA
Hasebe, S., Kusaka, T., Tanaka, M., Iwane, S., Tsuji, T., Kushida, H., Nakamura, M., Nakamura, M., Fujiwara, T., & Kikuta, M. (2025). Dual drivers of polypharmacy in people with HIV : Quantifying the independent associations of aging and long‐term antiretroviral therapy. HIV Medicine. https://doi.org/10.1111/hiv.70106
Vancouver
Hasebe S, Kusaka T, Tanaka M, Iwane S, Tsuji T, Kushida H, et al. Dual drivers of polypharmacy in people with HIV : Quantifying the independent associations of aging and long‐term antiretroviral therapy. HIV Medicine. 2025. doi:10.1111/hiv.70106
BibTeX
@article{Hasebe2025,
author = {Hasebe, Shigeru and Kusaka, Taiki and Tanaka, Masayuki and Iwane, Shiori and Tsuji, Toshikazu and Kushida, Hiroyuki and Nakamura, Mari and Nakamura, Masahiro and Fujiwara, Takumi and Kikuta, Maho},
title = {Dual drivers of polypharmacy in people with HIV : Quantifying the independent associations of aging and long‐term antiretroviral therapy},
journal = {HIV Medicine},
year = {2025},
doi = {10.1111/hiv.70106}
}
EUVIMED